Leo Fondet 2020 AR2
The report outlines the LEO Foundation's activities and financial performance for the fiscal year 2020. Despite the challenges of the COVID-19 pandemic, the LEO Group progressed on its strategic ambitions, launching LEO Pharma's 2030 strategy to become a global leader in medical dermatology. The Foundation awarded 25 grants and awards totaling DKK 72 million to support international skin research. Financially, the Group delivered a net loss of DKK 410 million, while the investment portfolio generated a solid return of DKK 968 million. Additionally, the Foundation strengthened its ESG profile and became a signatory to the Tax Code of Conduct to promote responsible tax behavior.
Company: Leo Fondet
Sector: Finance & insurance
Country: Denmark
Year: 2020
Type: AR2
Pages: 77
Back to company
Leo Fondet
Annual Report
The report outlines the LEO Foundation's activities and financial performance for the fiscal year 2020. Despite the challenges of the COVID-19 pandemic, the LEO Group progressed on its strategic ambitions, launching LEO Pharma's 2030 strategy to become a global leader in medical dermatology. The Foundation awarded 25 grants and awards totaling DKK 72 million to support international skin research. Financially, the Group delivered a net loss of DKK 410 million, while the investment portfolio generated a solid return of DKK 968 million. Additionally, the Foundation strengthened its ESG profile and became a signatory to the Tax Code of Conduct to promote responsible tax behavior.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees